Imricor Medical Systems received FDA clearances to expand its NorthStar system and Vision-MR diagnostic catheter to paediatric patients. Following the announcement, the company's share price rose ...
Echo IQ has secured firm commitments to raise approximately $110 million through an institutional share placement. The placement shares are priced at $1.45 each, representing an 8.8% discount to the ...
Coinbase will cut about 14% of its workforce, or roughly 700 jobs, as it restructures operations amid a market downturn and a shift toward artificial intelligence. CEO Brian Armstrong said the company ...
Genmab (NASDAQ:GMAB) presented new data at the 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Monday, demonstrating that its investigational antibody-drug conjugate (ADC), rinatabart ...
IREN has finalized the buyout of Ingenostrum, S.L. (Nostrum Group), establishing its first operational footprint in Europe. The transaction absorbs 490MW of secured, grid-connected power capacity in ...
Texas Instruments (NASDAQ:TXN) reported its financial results for the first quarter of 2026, signaling a significant recovery in the semiconductor sector. The Dallas-based chipmaker achieved revenue ...
Hims & Hers (NYSE:HIMS) posted first-quarter revenue of $608.1 million, a 4% increase compared to $586 million in the prior-year period. However, the company’s gross margin fell to 65% from 73% a year ...
Oracle (NYSE:ORCL) reported record fourth-quarter and full-year 2026 financial results, with broad-based growth across its Cloud Infrastructure and Cloud Applications businesses. Total Q4 revenues ...
UnitedHealth Group (NYSE:UNH) today reported financial results for the first quarter of 2026, delivering growth across its primary business platforms and raising its full-year earnings outlook. The ...
AstraZeneca (NASDAQ:AZN) unveiled positive data from its late-stage EMERALD-3 clinical trial on Monday, demonstrating that adding its dual-immunotherapy regimen to standard localized therapy ...
Amazon.com (NASDAQ:AMZN) reported financial results for the first quarter ended March 31, 2026, delivering a significant beat on the bottom line as the company’s cloud and artificial intelligence ...
Immunovant (NASDAQ:IMVT) announced its corporate updates and financial results for the fourth quarter and full fiscal year ended March 31, 2026, confirming the formal termination of its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results